UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1
Clinical trials for UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 trials appear
Sign up with your email to follow new studies for UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Second shot at radiation therapy tested for Tough-to-Treat gut cancers
Disease control Recruiting nowThis study is for adults with advanced neuroendocrine tumors in the digestive system that have spread and cannot be removed by surgery, and have worsened after a previous course of a targeted radiation therapy. It aims to see if getting a second course of that same radiation trea…
Matched conditions: UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New Two-Pronged attack on Tough-to-Treat gut tumors
Disease control Recruiting nowThis early-stage study is testing whether combining two radiation-based treatments is safe and more effective for controlling large, inoperable neuroendocrine tumors in the digestive system. Participants first receive a highly focused, external radiation treatment, followed by a …
Matched conditions: UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC